The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nifedipine-Global Market Insights and Sales Trends 2025
Synopsis
Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries.
The global Nifedipine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nifedipine in various end use industries. The expanding demands from the Primary Pulmonary Hypertension, Heart Failure and Others,, are propelling Nifedipine market. Nifedipine Controlled Release Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nifedipine Extended Action Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nifedipine market, driven by demand from China, the second largest economy with some signs of stabilising, the Nifedipine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nifedipine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nifedipine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nifedipine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nifedipine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nifedipine covered in this report include Bayer, Actavis, Teva, Pfizer, Shyndec, Honglin, Huanghai and Yabao, etc.
The global Nifedipine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Actavis
Teva
Pfizer
Shyndec
Honglin
Huanghai
Yabao
Global Nifedipine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nifedipine market, Segment by Type:
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Global Nifedipine market, by Application
Primary Pulmonary Hypertension
Heart Failure
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nifedipine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nifedipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries.
The global Nifedipine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nifedipine in various end use industries. The expanding demands from the Primary Pulmonary Hypertension, Heart Failure and Others,, are propelling Nifedipine market. Nifedipine Controlled Release Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nifedipine Extended Action Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nifedipine market, driven by demand from China, the second largest economy with some signs of stabilising, the Nifedipine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nifedipine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nifedipine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nifedipine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nifedipine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nifedipine covered in this report include Bayer, Actavis, Teva, Pfizer, Shyndec, Honglin, Huanghai and Yabao, etc.
The global Nifedipine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Actavis
Teva
Pfizer
Shyndec
Honglin
Huanghai
Yabao
Global Nifedipine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nifedipine market, Segment by Type:
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Global Nifedipine market, by Application
Primary Pulmonary Hypertension
Heart Failure
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nifedipine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nifedipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Nifedipine Market Overview
1.1 Nifedipine Product Overview
1.2 Nifedipine Market Segment by Type
1.2.1 Nifedipine Controlled Release Tablets
1.2.2 Nifedipine Extended Action Tablets
1.3 Global Nifedipine Market Size by Type
1.3.1 Global Nifedipine Market Size Overview by Type (2018-2029)
1.3.2 Global Nifedipine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Nifedipine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nifedipine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Nifedipine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Nifedipine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Nifedipine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Nifedipine Sales Breakdown by Type (2018-2023)
2 Global Nifedipine Market Competition by Company
2.1 Global Top Players by Nifedipine Sales (2018-2023)
2.2 Global Top Players by Nifedipine Revenue (2018-2023)
2.3 Global Top Players by Nifedipine Price (2018-2023)
2.4 Global Top Manufacturers Nifedipine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nifedipine Market Competitive Situation and Trends
2.5.1 Nifedipine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Nifedipine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nifedipine as of 2022)
2.7 Date of Key Manufacturers Enter into Nifedipine Market
2.8 Key Manufacturers Nifedipine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nifedipine Status and Outlook by Region
3.1 Global Nifedipine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Nifedipine Historic Market Size by Region
3.2.1 Global Nifedipine Sales in Volume by Region (2018-2023)
3.2.2 Global Nifedipine Sales in Value by Region (2018-2023)
3.2.3 Global Nifedipine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Nifedipine Forecasted Market Size by Region
3.3.1 Global Nifedipine Sales in Volume by Region (2024-2029)
3.3.2 Global Nifedipine Sales in Value by Region (2024-2029)
3.3.3 Global Nifedipine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Nifedipine by Application
4.1 Nifedipine Market Segment by Application
4.1.1 Primary Pulmonary Hypertension
4.1.2 Heart Failure
4.1.3 Others
4.2 Global Nifedipine Market Size by Application
4.2.1 Global Nifedipine Market Size Overview by Application (2018-2029)
4.2.2 Global Nifedipine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Nifedipine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nifedipine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Nifedipine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Nifedipine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Nifedipine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Nifedipine Sales Breakdown by Application (2018-2023)
5 North America Nifedipine by Country
5.1 North America Nifedipine Historic Market Size by Country
5.1.1 North America Nifedipine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Nifedipine Sales in Volume by Country (2018-2023)
5.1.3 North America Nifedipine Sales in Value by Country (2018-2023)
5.2 North America Nifedipine Forecasted Market Size by Country
5.2.1 North America Nifedipine Sales in Volume by Country (2024-2029)
5.2.2 North America Nifedipine Sales in Value by Country (2024-2029)
6 Europe Nifedipine by Country
6.1 Europe Nifedipine Historic Market Size by Country
6.1.1 Europe Nifedipine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Nifedipine Sales in Volume by Country (2018-2023)
6.1.3 Europe Nifedipine Sales in Value by Country (2018-2023)
6.2 Europe Nifedipine Forecasted Market Size by Country
6.2.1 Europe Nifedipine Sales in Volume by Country (2024-2029)
6.2.2 Europe Nifedipine Sales in Value by Country (2024-2029)
7 Asia-Pacific Nifedipine by Region
7.1 Asia-Pacific Nifedipine Historic Market Size by Region
7.1.1 Asia-Pacific Nifedipine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Nifedipine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Nifedipine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Nifedipine Forecasted Market Size by Region
7.2.1 Asia-Pacific Nifedipine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Nifedipine Sales in Value by Region (2024-2029)
8 Latin America Nifedipine by Country
8.1 Latin America Nifedipine Historic Market Size by Country
8.1.1 Latin America Nifedipine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Nifedipine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Nifedipine Sales in Value by Country (2018-2023)
8.2 Latin America Nifedipine Forecasted Market Size by Country
8.2.1 Latin America Nifedipine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Nifedipine Sales in Value by Country (2024-2029)
9 Middle East and Africa Nifedipine by Country
9.1 Middle East and Africa Nifedipine Historic Market Size by Country
9.1.1 Middle East and Africa Nifedipine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Nifedipine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Nifedipine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Nifedipine Forecasted Market Size by Country
9.2.1 Middle East and Africa Nifedipine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Nifedipine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Nifedipine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Nifedipine Products Offered
10.1.5 Bayer Recent Development
10.2 Actavis
10.2.1 Actavis Company Information
10.2.2 Actavis Introduction and Business Overview
10.2.3 Actavis Nifedipine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Actavis Nifedipine Products Offered
10.2.5 Actavis Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Nifedipine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Nifedipine Products Offered
10.3.5 Teva Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Nifedipine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Nifedipine Products Offered
10.4.5 Pfizer Recent Development
10.5 Shyndec
10.5.1 Shyndec Company Information
10.5.2 Shyndec Introduction and Business Overview
10.5.3 Shyndec Nifedipine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Shyndec Nifedipine Products Offered
10.5.5 Shyndec Recent Development
10.6 Honglin
10.6.1 Honglin Company Information
10.6.2 Honglin Introduction and Business Overview
10.6.3 Honglin Nifedipine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Honglin Nifedipine Products Offered
10.6.5 Honglin Recent Development
10.7 Huanghai
10.7.1 Huanghai Company Information
10.7.2 Huanghai Introduction and Business Overview
10.7.3 Huanghai Nifedipine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Huanghai Nifedipine Products Offered
10.7.5 Huanghai Recent Development
10.8 Yabao
10.8.1 Yabao Company Information
10.8.2 Yabao Introduction and Business Overview
10.8.3 Yabao Nifedipine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Yabao Nifedipine Products Offered
10.8.5 Yabao Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nifedipine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nifedipine Industrial Chain Analysis
11.4 Nifedipine Market Dynamics
11.4.1 Nifedipine Industry Trends
11.4.2 Nifedipine Market Drivers
11.4.3 Nifedipine Market Challenges
11.4.4 Nifedipine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nifedipine Distributors
12.3 Nifedipine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
